British pharmaceutical giant Astrazeneca Monday opened a 78 million us dollar research facility in bangalore, its first outside the United States and Europe, to conduct research on tuberculosis Lrb TB Rrb and other infectious diseases.
British Pharma giant opens research unit in India.